DGRW vs XLV
WisdomTree US Quality Dividend Growth Fund vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.28% for DGRW.
- • XLV pays a higher dividend yield (1.38%).
Side-by-side metrics
| Metric | DGRW | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.28% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.24% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $16.93B | $49.10B |
YTD return | 11.01% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.78 | 0.41 |
P/E ratio | 24.10 | 30.63 |
Last price | $98.82 | $187.94 |
Inception | — | — |
Issuer | WisdomTree | State Street |
DGRW top holdings
| NVDA | NVIDIA Corp | 7.89% |
| MSFT | Microsoft Corp | 7.81% |
| AAPL | Apple Inc | 4.47% |
| KO | Coca-Cola Co | 3.24% |
| META | Meta Platforms Inc Class A | 3.15% |
| UNH | UnitedHealth Group Inc | 2.78% |
| HD | The Home Depot Inc | 2.54% |
| JNJ | Johnson & Johnson | 2.45% |
| ABBV | AbbVie Inc | 2.36% |
| XOM | ExxonMobil Holdings Corp | 2.12% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About DGRW
DGRW (WisdomTree US Quality Dividend Growth Fund) is Dividend-paying US large caps with quality and growth screens. Managed by WisdomTree, the fund carries $16.9B in assets under management, an expense ratio of 0.28%, a dividend yield of 1.24%. Its largest holding is NVIDIA Corp (NVDA), which represents 7.9% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 7.3%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.